These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2943311)

  • 1. Oral spironolactone: an effective treatment for acne vulgaris in women.
    Muhlemann MF; Carter GD; Cream JJ; Wise P
    Br J Dermatol; 1986 Aug; 115(2):227-32. PubMed ID: 2943311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
    Poinas A; Lemoigne M; Le Naour S; Nguyen JM; Schirr-Bonnans S; Riche VP; Vrignaud F; Machet L; Claudel JP; Leccia MT; Hainaut E; Beneton N; Dert C; Boisrobert A; Flet L; Chiffoleau A; Corvec S; Khammari A; Dréno B
    Trials; 2020 Jun; 21(1):571. PubMed ID: 32586344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral spironolactone improves acne vulgaris and reduces sebum excretion.
    Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P
    Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone and cimetidine in treatment of acne.
    Hatwal A; Bhatt RP; Agrawal JK; Singh G; Bajpai HS
    Acta Derm Venereol; 1988; 68(1):84-7. PubMed ID: 2449021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
    Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
    Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
    Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Lee O; Farquhar C; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2000; (2):CD000194. PubMed ID: 10796700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
    Rosen MP; Breitkopf DM; Nagamani M
    Am J Obstet Gynecol; 2003 May; 188(5):1158-60. PubMed ID: 12748463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty.
    Odlind V; Carlström K; Michaëlsson G; Vahlqvist A; Victor A; Mellbin T
    Clin Endocrinol (Oxf); 1982 Mar; 16(3):243-9. PubMed ID: 6210470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women.
    Renz S; Chinnery F; Stuart B; Day L; Muller I; Soulsby I; Nuttall J; Thomas K; Thomas KS; Sach T; Stanton L; Ridd MJ; Francis N; Little P; Eminton Z; Griffiths G; Layton AM; Santer M
    BMJ Open; 2021 Aug; 11(8):e053876. PubMed ID: 34446504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
    Santer M; Lawrence M; Renz S; Eminton Z; Stuart B; Sach TH; Pyne S; Ridd MJ; Francis N; Soulsby I; Thomas K; Permyakova N; Little P; Muller I; Nuttall J; Griffiths G; Thomas KS; Layton AM;
    BMJ; 2023 May; 381():e074349. PubMed ID: 37192767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea.
    Wang HS; Wang TH; Soong YK
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):423-32. PubMed ID: 10584414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial.
    Kelidari HR; Saeedi M; Hajheydari Z; Akbari J; Morteza-Semnani K; Akhtari J; Valizadeh H; Asare-Addo K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2016 Oct; 146():47-53. PubMed ID: 27248464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.